| Selected scientific publications about CHROMagar Candida |
-
CHROMagar Candida, a new differential isolation medium for the presumptive identification of clinically important Candida species.
Odds F. et al.
1994, Journal of Clinical Microbiology, 32 : 1923-1929.
-
Use of CHROMagar Candida medium for isolation of yeasts from dental samples.
Beighton D. et al.
1995. Journal of Clinical Microbiology, 33 : .3025-3027.
-
Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.
Pfaller M.A. et al.
1996. Journal of Clinical Microbiology, 34 : 58-61.
-
Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations.
Bouchara J.P. et al.
1996. Technical Report, 202-208.
-
Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.
Patterson T. et al.
1996. Journal of Clinical Microbiology, 34 : 1794-1797.
-
Appearance of colonies of Prototheca on CHROMagar Candida medium.
Casal M. et al.
1997. Mycopathologia, 137 : 79-82
-
Molecular and phenotypic analysis of Candida dubliniensis : a recently identified species linked with oral candidosis in HIV-infected and AIDS patients.
Coleman D. et al.
1997. Oral Diseases, 3 : 96-101.
-
Use of CHROMagar Candida for genital specimens in the diagnostic laboratory.
Houang E.T.S. et al.
1997. Journal Clinical Pathology, 50 : 563-565.
-
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.
Schoofs A., Odds F.C. et al.
1997. Eur. J. Clin. Microbiol. Infect. Dis., 16 : 296-300.
-
Candida species from genital sites: their identification and susceptibility to fluconazole.
Sim E. A. and Hughes C.
1998. British Journal of Biomedical Science, 55: 264-267.
-
Diferenciacion e identificacion presuntiva rapida de levaduras con el medio CHROMagar Candida (article in Spanish).
Giusiano G. E. et al.
1998. Revista Argentina de Microbiologia, 30: 100-103.
-
An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory.
Ainscough S. et al.
1998. J. Med. Microbiol., 47 : 623-628.
-
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates.
Kirkpatrick W. R. et al.
1998. Journal of Clinical Microbiology, 36 :3007-3012.
-
Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory.
Koehler A. P. et al.
1999. Journal of Clinical Microbiology, 37: 422-426.
-
Candida dubliniensis: An update
Sullivan D. J., D.C. Coleman et al.
1999. Rev. Iberoam Micol.,16 : 72-76.
-
Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species.
Willinger B., Manafi M.
1999. Mycoses, 42 : 61-65.
-
Replacement of Candida albicans with Candida dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M., Patterson T. et al.
2002. Journal of Clinical Microbiology, 40 : 3135-3139.
-
Case report : Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
Redding S. W. et al
2002. Journal of Clinical Microbiology, 40 : 1879-1881.
-
Detection of fluconazole-resistant isolates of Candida glabrata by using an agar screen assay.
Nelson S. M. et al.
2003. Journal of Clinical Microbiology, 41 : 2141-2143.
